296 related articles for article (PubMed ID: 19181718)
1. APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.
Niti M; Yap KB; Kua EH; Ng TP
J Gerontol A Biol Sci Med Sci; 2009 Feb; 64(2):306-11. PubMed ID: 19181718
[TBL] [Abstract][Full Text] [Related]
2. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
Ma F; Wang J; Miao R; Zhao W; Wang Q
Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
[TBL] [Abstract][Full Text] [Related]
3. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.
Rajan KB; Wilson RS; Skarupski KA; Mendes de Leon CF; Evans DA
Psychosom Med; 2014 Feb; 76(2):101-8. PubMed ID: 24434953
[TBL] [Abstract][Full Text] [Related]
4. Albumin, apolipoprotein E-epsilon4 and cognitive decline in community-dwelling Chinese older adults.
Ng TP; Niti M; Feng L; Kua EH; Yap KB
J Am Geriatr Soc; 2009 Jan; 57(1):101-6. PubMed ID: 19054180
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults.
Corsentino EA; Sawyer K; Sachs-Ericsson N; Blazer DG
Am J Geriatr Psychiatry; 2009 Feb; 17(2):155-65. PubMed ID: 19155747
[TBL] [Abstract][Full Text] [Related]
7. Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction.
Feng L; Li J; Yap KB; Kua EH; Ng TP
Am J Clin Nutr; 2009 Apr; 89(4):1263-8. PubMed ID: 19244370
[TBL] [Abstract][Full Text] [Related]
8. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
9. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
10. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.
Bretsky P; Guralnik JM; Launer L; Albert M; Seeman TE;
Neurology; 2003 Apr; 60(7):1077-81. PubMed ID: 12682309
[TBL] [Abstract][Full Text] [Related]
11. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G
Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
Irie F; Masaki KH; Petrovitch H; Abbott RD; Ross GW; Taaffe DR; Launer LJ; White LR
Arch Gen Psychiatry; 2008 Aug; 65(8):906-12. PubMed ID: 18678795
[TBL] [Abstract][Full Text] [Related]
14. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies.
Gao Q; Niti M; Feng L; Yap KB; Ng TP
J Nutr Health Aging; 2011 Jan; 15(1):32-5. PubMed ID: 21267519
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and cognitive decline in chinese older adults: results from the singapore longitudinal ageing studies.
Ho RC; Niti M; Yap KB; Kua EH; Ng TP
Am J Geriatr Psychiatry; 2008 Jun; 16(6):519-22. PubMed ID: 18515697
[TBL] [Abstract][Full Text] [Related]
17. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
Mormino EC; Betensky RA; Hedden T; Schultz AP; Ward A; Huijbers W; Rentz DM; Johnson KA; Sperling RA; ; ;
Neurology; 2014 May; 82(20):1760-7. PubMed ID: 24748674
[TBL] [Abstract][Full Text] [Related]
18. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
19. The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
Bour AM; Rasquin SM; Baars L; van Boxtel MP; Visser PJ; Limburg M; Verhey FR
Dement Geriatr Cogn Disord; 2010; 29(6):534-42. PubMed ID: 20606435
[TBL] [Abstract][Full Text] [Related]
20. Depression, cognition, apolipoprotein e genotype: latent class approach to identifying subtype.
Bogner HR; Richie MB; de Vries HF; Morales KH
Am J Geriatr Psychiatry; 2009 Apr; 17(4):344-52. PubMed ID: 19307863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
